Women Taking HRT For Menopause Have A Lower Risk Of Dementia, New Study Suggests
According to a new study, women who use hormone replacement therapy (HRT) may have a reduced risk of dementia.
The study itself took place in the United Kingdom and was the largest of its kind, tracking over 180,000 post menopausal women. The scientists found that the participants who used HRT were 10% less likely to develop any kind of dementia and 16% less likely to be diagnosed with Alzheimer’s, compared to those who never used it, according to reports.
The study and its findings were published in the journal Alzheimer’s & Dementia, and was led by Professor Anne-Marie Minihane, who is also the director of the Norwich Institute for Healthy Aging at the University of East Anglia.
Minihane revealed that they saw the greatest risk reduction in women using HRT who also underwent surgical menopause, finding a 26% lower risk of developing any type of dementia compared to women who didn’t use the therapy.
“While HRT has long been prescribed primarily to relieve menopausal symptoms such as hot flashes and night sweats, this work suggests it may also play a role in long-term cognitive health for some women.”
Women are more likely to develop dementia due to the fact that, statistically, they live longer than men. Scientists also think it could be related to the impact of menopause on their brain metabolism and the impact of the main risk gene for Alzheimer’s being greater on women.
“We wanted to better understand how HRT could prevent dementia and to assess if particular groups of women may respond differently,” Minihane said.
The study used data from the UK Biobank, allowing them to track 183,450 postmenopausal women over about 13 years. Throughout that timespan almost 4,000 cases of dementia were identified, and the scientists looked at whether or not using HRT of any kind for at least one year changed women’s risk of developing dementia.
The study also pointed out that women who naturally had lower oestrogen exposure throughout their life, either due to starting their periods late or going through early menopause, would benefit more from HRT, with a 16% lower risk of any kind of dementia.
Of course, genetics also play a role. Women who carried the Apoe4 gene had a stronger association with HRT use and dementia.
“This is really important because Apoe4 carriers are typically considered at higher risk and have fewer established prevention options,” said Minihane.
The results of this study are based on observational data rather than a randomized-controlled trial, so there’s no way to prove a causal link.
Dr Susan Kohlhaas, the executive director of research and partnerships at Alzheimer’s Research UK, said:
“This study alone isn’t enough to tell us whether HRT should be used to reduce dementia risk, but it provides further evidence that the timing of HRT and a woman’s hormonal history may matter.
“We now need research that can establish whether HRT itself is responsible for these differences in dementia risk and understand which forms of HRT may have an effect.
“Anyone considering starting or stopping HRT should speak to their GP about the potential benefits and risks for them.”
Eric Mastrota is a Contributing Editor at The National Digest based in New York. A graduate of SUNY New Paltz, he reports on world news, culture, and lifestyle. You can reach him at eric.mastrota@thenationaldigest.com.










